Beta-adrenergic signaling, a novel target for cancer therapy?

Oncotarget. 2010 Nov;1(7):466-9. doi: 10.18632/oncotarget.101102.
No abstract available

Publication types

  • Evaluation Study
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / complications
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Carcinoma / complications
  • Carcinoma / drug therapy
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Female
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Molecular Targeted Therapy / methods*
  • Molecular Targeted Therapy / trends
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Propranolol / therapeutic use
  • Receptors, Adrenergic, beta / metabolism
  • Receptors, Adrenergic, beta / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Survival Analysis

Substances

  • Adrenergic beta-Antagonists
  • Antineoplastic Agents
  • Receptors, Adrenergic, beta
  • Propranolol